Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-033403
Filing Date
2013-06-24
Accepted
2013-06-24 16:52:33
Documents
1
Period of Report
2013-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4228
  Complete submission text file 0001209191-13-033403.txt   5653
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VANDA PHARMACEUTICALS INC 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Galson Steven K (Reporting) CIK: 0001495328 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 13930094